Key result
Agents that do not lower cholesterol can modify the progression of atherosclerosis.
Does not support practice change; leaves open non-lipid pathways for atherosclerosis modification.
Modification of atherosclerosis by
No takes yet. Share an insight, caveat, or question.
Cleland et al. (1993) studied this question. Agents that do not lower cholesterol can modify the progression of atherosclerosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: